Highlights
NASDAQ: AKCA       Akcea Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
18.54   -0.31 (1.64%)  18.43 - 18.92  94,051

Overview

 
Avg Volume (4 weeks):316,788
4 Weeks Range:16.15 - 20.10
4 Weeks Price Volatility (%):
60.51%
52 Weeks Range:13.90 - 35.82
52 Weeks Price Volatility (%):
21.17%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. It is advancing a mature pipeline of novel drugs with the potential to treat multiple diseases. The company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc. Its most advanced drug, volanesorsen, has completed a Phase 3 clinical program for the treatment of familial chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of familial partial lipodystrophy, or FPL.

  Be the first to like this.
 


 

2291  3276  427  2970 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 12.90+1.17 
 ACHN 6.760.00 
 AMD 46.75-3.78 
 AVP 5.60-0.05 
 CHK 0.557+0.039 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 AAPL 327.43+9.74 
Partners & Brokers